Cytokine Secretion in Long-standing Diabetes Mellitus Type 1 and 2: Associations with Low-grade Systemic Inflammation

被引:0
作者
Krystallenia I. Alexandraki
Christina Piperi
Panayiotis D. Ziakas
Nikolaos V. Apostolopoulos
Konstantinos Makrilakis
Vassiliki Syriou
Evanthia Diamanti-Kandarakis
Gregory Kaltsas
Anastasios Kalofoutis
机构
[1] National and Kapodistrian University of Athens,Laboratory of Biological Chemistry, School of Medicine
[2] National and Kapodistrian University of Athens,Division of Endocrinology, Department of Pathophysiology, Laiko University Hospital, School of Medicine
[3] Homerton University Hospital,Department of Obstetrics and Gynecology
[4] National and Kapodistrian University of Athens,Diabetologic Center, First Department of Propedeutic Medicine, Laiko University Hospital, School of Medicine
[5] National and Kapodistrian University of Athens,Division of Endocrinology, First Department of Medicine, School of Medicine
[6] University of Athens Medical School,undefined
来源
Journal of Clinical Immunology | 2008年 / 28卷
关键词
Cytokines; C-reactive protein; interleukin-1β; interleukin-6; tumor necrosis factor-α; diabetes mellitus type 1; diabetes mellitus type 2; peripheral blood mononuclear cells; ELISPOT;
D O I
暂无
中图分类号
学科分类号
摘要
Low-grade systemic chronic inflammation is a very well-known feature of diabetes mellitus (DM). The purpose of this study was the assessment of the proinflammatory cytokine secretion profile in long-standing diabetes along with the presence of features of systemic inflammation. Metabolic parameters and serum high-sensitivity C-reactive protein, interleukin-1β, interleukin-6, and tumor necrosis factor-α levels were determined in 20 patients with type 1 DM and 21 patients with type 2 DM and compared to 34 healthy subjects. The number of cytokine-secreting peripheral blood mononuclear cells (PBMCs), before and after mitogenic stimulation, was also determined in the same groups. Adverse lipid profile, higher levels of inflammatory markers, and higher count of cytokine-secreting cells were observed more prevalently in type 2 diabetics than in controls. After stimulation, the increase in number of cytokine-secreting cells was higher in controls. In conclusion, patients with DM have evidence of low-grade inflammation and abnormal PBMC function that could be related to long-term sequelae, the accelerated atherosclerotic process, and the susceptibility to infections.
引用
收藏
页码:314 / 321
页数:7
相关论文
共 249 条
[1]  
Pickup JC(1998)Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41 1241-1248
[2]  
Crook MA(2003)Role of cytokines in the pathogenesis of autoimmune diabetes mellitus Rev Endocr Metab Disord 4 291-299
[3]  
Rabinovitch A(1998)IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses J Clin Invest 101 311-320
[4]  
Suarez-Pinzon WL(2001)Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications Diabetes Care 24 956-957
[5]  
Xing Z(1999)Inflammatory markers in men with angiographically documented coronary heart disease Clin Chem 45 1967-1973
[6]  
Gauldie J(2006)Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus Mediators Inflamm 2006 39062-1292
[7]  
Cox G(1997)NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X Diabetologia 40 1286-100
[8]  
Baumann H(1975)The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum Am J Pathol 78 71-509
[9]  
Jordana M(1999)Neutrophil-derived proteins: selling cytokines by the pound Adv Immunol 73 369-650
[10]  
Lei XF(2001)Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children Clin Biochem 34 645-234